Sarcopenia in Head and Neck Cancer Patients Treated With Curative Hadrontherapy - Trial NCT06207708
Access comprehensive clinical trial information for NCT06207708 through Pure Global AI's free database. This phase not specified trial is sponsored by CNAO National Center of Oncological Hadrontherapy and is currently Recruiting. The study focuses on Head and Neck Cancer. Target enrollment is 70 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
questionnaires QLQ-FA12, Mini Nutritional Assessment Short Form, Nutritional Risk Screening, diet questionnaire of frequency, ,body mass index measurement
Observational
other
Sponsor & Location
CNAO National Center of Oncological Hadrontherapy
Timeline & Enrollment
N/A
Apr 18, 2023
Nov 18, 2024
Primary Outcome
skeletal muscle strength mass (SMM)
Summary
The study focuses on the impact of sarcopenia on acute and late toxicities in head and neck
 tumor affected patients treated with particle therapy.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06207708
Non-Device Trial